BioMelbourne Network
Progressing BioIndustry
Book an event
14th August - BioBreakfast
Biomarkers Making a Mark in Cancer Therapies
Advances in genomics, biotechnology and molecular pathology have generated many candidate biomarkers that are being used to select patients predisposed to respond to specific cancer therapies and to predict their likely prognosis. Event Description
| When: |
Tuesday, 14th August, 2012 Registration: - 7.15am Buffet Breakfast 7.25am till 7.55am Presentation: 8.00am till 9.00am. |
|---|---|
| Where: |
Shell Auditorium & Conference Centre 1 Spring Street, Melbourne |
| Speakers: |
Professor Paul Waring Chair and Head of Pathology Department University of Melbourne |
| Price: |
Members $65.00 Non Members $95.00 (Prices include GST) Cancellation Policy: Full refund given up to 7 days prior to the event. No refunds within 7 days of the event. |
| RSVP: | Thursday, 9th August, 2012 |
About This Event
Advances in genomics, biotechnology and molecular pathology have generated many candidate biomarkers that are being used to select patients predisposed to respond to specific cancer therapies and to predict their likely prognosis.
The current trend in cancer care is personalized medicine, in which treatment programs are individualized to provide the best care for you based on certain biological characteristics you have. Two events that have made this trend possible are the discovery of biomarkers and their offspring targeted therapies. Biomarkers are substances found in blood, other body fluids, or tissues that signal the presence of absence of a condition or disease, such as cancer. They can also be used in monitoring patients to determine whether a disease is progressing, the effect of treatment, and the toxicity of treatment.
Cancer biomarkers may serve to reduce the total cost of cancer care, deliver improved patient outcomes, reduce the time between diagnosis and effective treatment and offer an attractive commercial opportunity for those who are developing the technologies for the oncology market. The therapeutic promise and commercial potential is significant.
Are biomarkers delivering on this promise and marking a positive mark in clinical practice and delivering commercial results ?
About the Speakers
Professor Paul Waring
Chair and Head of Pathology Department, University of Melbourne
Event Location
Shell Auditorium & Conference Centre
1 Spring Street, Melbourne
